Author:
Drullion C,Trégoat C,Lagarde V,Tan S,Gioia R,Priault M,Djavaheri-Mergny M,Brisson A,Auberger P,Mahon F-X,Pasquet J-M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference44 articles.
1. Melo JV . The molecular biology of chronic myeloid leukaemia. Leukemia 1996; 10: 751–756.
2. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561–566.
3. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139–145.
4. Ertmer A, Huber V, Gilch S, Yoshimori T, Erfle V, Duyster J et al. The anticancer drug imatinib induces cellular autophagy. Leukemia 2007; 21: 936–942.
5. Puissant A, Colosetti P, Robert G, Cassuto JP, Raynaud S, Auberger P . Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia 2010; 24: 115–124.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献